We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

85 hedge funds and large institutions have $269M invested in Intellia Therapeutics in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 10

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

54% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $778K

14% more capital invested

Capital invested by funds: $236M → $269M (+$33M)

12% more funds holding

Funds holding: 76 → 85 (+9)

0.19% more ownership

Funds ownership: 46.47% → 46.66% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
85
Holders Change
+9
Holders Change %
+11.84%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
36
Reduced
10
Closed
12
Calls
$1.2M
Puts
$778K
Net Calls
+$420K
Net Calls Change
+$541K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.2M
2
GIM
Granahan Investment Management
Massachusetts
+$3.74M
3
AIM
ARK Investment Management
Florida
+$1.33M
4
USAA
United Services Automobile Association
Texas
+$1.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.8M
2
GC
GMT Capital
Georgia
-$4.66M
3
Franklin Resources
Franklin Resources
California
-$4.23M
4
FCMI
Foresite Capital Management III
California
-$2.11M
5
SM
Sabby Management
Florida
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$683K +$220K +15,771 +59%
Northern Trust
27
Northern Trust
Illinois
$585K -$555K -39,699 -52%
American Century Companies
28
American Century Companies
Missouri
$583K +$509K +36,423 New
LCM
29
Landscape Capital Management
New Jersey
$574K +$501K +35,867 New
AllianceBernstein
30
AllianceBernstein
Tennessee
$486K +$64.3K +4,600 +18%
Wells Fargo
31
Wells Fargo
California
$483K +$269K +19,270 +176%
Millennium Management
32
Millennium Management
New York
$459K +$39K +2,791 +11%
AL
33
Airain Ltd
Guernsey
$449K +$14.3K +1,027 +4%
TCM
34
Tekla Capital Management
Massachusetts
$448K -$613K -43,842 -61%
Deutsche Bank
35
Deutsche Bank
Germany
$430K +$350K +25,074 +1,325%
TA
36
Teachers Advisors
New York
$417K +$209K +14,991 +135%
Bank of America
37
Bank of America
North Carolina
$405K +$104K +7,465 +42%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$402K +$155K +11,100 +79%
Swiss National Bank
39
Swiss National Bank
Switzerland
$331K – – –
ProShare Advisors
40
ProShare Advisors
Maryland
$316K -$3.77K -270 -1%
EMG
41
Ellington Management Group
Connecticut
$307K +$268K +19,200 New
Renaissance Technologies
42
Renaissance Technologies
New York
$307K +$268K +19,200 New
AIMCA
43
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$298K -$442K -31,600 -63%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$275K +$240K +17,166 New
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$242K +$110K +7,899 +110%
Group One Trading
46
Group One Trading
Illinois
$214K +$65.3K +4,672 +54%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$212K +$151K +10,825 +451%
VKH
48
Virtu KCG Holdings
New York
$203K +$177K +12,697 New
AQR Capital Management
49
AQR Capital Management
Connecticut
$200K +$175K +12,503 New
M&T Bank
50
M&T Bank
New York
$184K – – –
1
2
3 4

NTLA Hedge Fund Activity: Q2 2017 in Review

85 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q2 2017, worth a combined $269M — up 14% from $236M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NTLA positions and 12 closed out — a net gain of 9 holders — while 36 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $10.2M. The largest seller was Fidelity Investments, cutting an estimated $10.8M.

  • 85 institutional investors held Intellia Therapeutics (NTLA) as of Q2 2017, up from 76 in Q1 2017.
  • Funds reported $269M of Intellia Therapeutics stock for Q2 2017, up 14% quarter-over-quarter.
  • 21 funds opened new Intellia Therapeutics positions in Q2 2017 and 12 closed out, a net change of +9 holders.
  • The largest Intellia Therapeutics buyer in Q2 2017 was BlackRock, an estimated $10.2M added.
  • The largest Intellia Therapeutics seller in Q2 2017 was Fidelity Investments, an estimated $10.8M sold.

Based on aggregated 13F filings for Q2 2017.